Article
Antibiotic Exposure in Infancy and Risk of Being Overweight in the First 24 Months of Life
Antti Saari, Lauri J. Virta, Ulla Sankilampi, Leo Dunkel and Harri Saxen
Pediatrics April 2015, 135 (4) 617-626; DOI: https://doi.org/10.1542/peds.2014-3407
Antti Saari
aDepartment of Pediatrics, School of Medicine, Faculty of Health Sciences, University of Eastern Finland, Kuopio, Finland;
bDepartment of Pediatrics, Kuopio University Hospital, Kuopio, Finland;
Lauri J. Virta
cDepartment of Research, Social Insurance Institution, Turku, Finland;
Ulla Sankilampi
bDepartment of Pediatrics, Kuopio University Hospital, Kuopio, Finland;
Leo Dunkel
dWilliam Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom; and
Harri Saxen
eChildren’s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Log in
You will be redirected to aap.org to login or to create your account.
Antibiotic Exposure in Infancy and Risk of Being Overweight in the First 24 Months of Life
Antti Saari, Lauri J. Virta, Ulla Sankilampi, Leo Dunkel, Harri Saxen
Pediatrics Apr 2015, 135 (4) 617-626; DOI: 10.1542/peds.2014-3407
Jump to section
Related Articles
Cited By...
- Antibiotics in hives and their effects on honey bee physiology and behavioral development
- Comparison of the management recommendations of the Kaiser Permanente neonatal early-onset sepsis risk calculator (SRC) with NICE guideline CG149 in infants >=34 weeks gestation who developed early-onset sepsis
- Screening for early onset neonatal sepsis: NICE guidance-based practice versus projected application of the Kaiser Permanente sepsis risk calculator in the UK population
- Dissecting the collateral damage of antibiotics on gut microbes
- A Collaborative Multicenter QI Initiative to Improve Antibiotic Stewardship in Newborns
- Association of the FilmArray Meningitis/Encephalitis Panel With Clinical Management
- Management of Infants at Risk for Group B Streptococcal Disease
- Management of Infants at Risk for Group B Streptococcal Disease
- Vital signs analysis algorithm detects inflammatory response in premature infants with late onset sepsis and necrotizing enterocolitis
- Universal antenatal screening for group B streptococcus may cause more harm than good
- Antibiotic and acid-suppression medications during early childhood are associated with obesity
- Variation in Antibiotic Selection and Clinical Outcomes in Infants <60 Days Hospitalized With Skin and Soft Tissue Infections
- Is There a Causal Link Between Antibiotic Exposure During Infancy and Risk for Obesity?
- Management of Neonates Born at >=35 0/7 Weeks Gestation With Suspected or Proven Early-Onset Bacterial Sepsis
- Early Antibiotic Exposure and Weight Outcomes in Young Children
- Advances in optimizing the prescription of antibiotics in outpatient settings
- Neonatal Antibiotic Use: What Are We Doing and Where Shall We Go?
- Emerging Technologies for Molecular Diagnosis of Sepsis
- Management of Pediatric Community-acquired Bacterial Pneumonia
- Extending Antimicrobial Stewardship to All Hospitalized Children: The Time Is Now
- Divergent Relationships between Fecal Microbiota and Metabolome following Distinct Antibiotic-Induced Disruptions
- Update on Pediatric Overuse
- Choosing Wrong
- Preterm infant growth and asthma at age 8 years
- The Cost of a Culture and Doctoring at a Distance
- Tip of the Iceberg: Understanding the Unintended Consequences of Antibiotics